American Portfolios Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMO
WA
CS
N
RCMU
APM
American Portfolios Advisors's SGMO Position: Q3 2022 in Review
American Portfolios Advisors held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q3 2022 at 450 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3094.
American Portfolios Advisors first reported a position in SGMO in Q4 2017 and has held it in 20 quarters since. The position peaked at $15.7K in Q3 2018. 197 funds tracked by Wall St. Rank hold SGMO as of Q3 2022.
- American Portfolios Advisors held 450 shares of SANGAMO THERAPEUTICS INC worth $2.21K as of Q3 2022.
- American Portfolios Advisors left its SANGAMO THERAPEUTICS INC share count unchanged in Q3 2022.
- SANGAMO THERAPEUTICS INC made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3094 holding.
- American Portfolios Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's SANGAMO THERAPEUTICS INC position peaked at $15.7K in Q3 2018.
- 197 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.